A Real-World Assessment of a COPD Disease Management Support Service (Me & My COPD).
Chronic Obstructive Pulmonary Disease
Endpoint Classification: -
Intervention Model: -
Primary Purpose: -
Verified 01 Aug 2018 by AstraZeneca
No locations available
This group of patients (n=250) will receive the digital service (smart phone application and bluetooth inhaler device) in addition to current best care from their healthcare professional.
Device: Test Group
Patients receive a mobile phone with the Me & My COPD app installed. Patients also receive a bluetooth inhaler device that is fitted to their usual reliever inhaler.
This group of patients (n=250) will receive current best care alone. Control patients will not have access to the digital service.
Other: Control Group
Patients in the control group receive only standard care; there are no interventions within this group of patients